Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Discovery|September 20, 2017
A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO InhibitorsXuesong Zhao, Ekaterina Pak, Kimberly J Ornell, et al.
Developmental Cell|March 31, 2015
The Eya1 phosphatase promotes Shh signaling during hindbrain development and oncogenesisAdriana Eisner, Maria F Pazyra-Murphy, Ershela Durresi, et al.
Acta Neuropathologica Communications|August 6, 2024
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastomaFoteini Tsiami, Chiara Lago, Noemi Pozza, et al.
Cancer Treatment Reviews|November 4, 2025
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapyXuesong Zhao, Qianyun Hao, Maria Alsina, et al.
Cancer Research|July 2, 2015
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent TumorsXuesong Zhao, Tatyana Ponomaryov, Kimberly J Ornell, et al.
Neuro-Oncology|May 22, 2019
A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastomaEkaterina Pak, Ethan L MacKenzie, Xuesong Zhao, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3Ryan A Brawn, Andrew Cook, Kiyoyuki Omoto, et al.
Developmental Neuroscience|January 20, 2021
The Eya1 Phosphatase Mediates Shh-Driven Symmetric Cell Division of Cerebellar Granule Cell PrecursorsDaniel J Merk, Pengcheng Zhou, Samuel M Cohen, et al.
Clinical Kidney Journal|December 4, 2023
Development of a multiple convolutional neural network-facilitated diagnostic screening program for immunofluorescence images of IgA nephropathy and idiopathic membranous nephropathyPeng Xia, Zhilong Lv, Yubing Wen, et al.
Therapeutics and Clinical Risk Management|January 14, 2021
Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort StudyShengyu Zhou, Jiawei Xu, Wenqing Sun, et al.
Pageof 10